Citius Pharmaceuticals, Inc. — Form D/A

Citius Pharmaceuticals, Inc. of CRANFORD, NJ, a company, filed a Form D amendment with the SEC on 2017-02-27. The offering totals $6.0M, of which $550K was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2017-02-27
• Form: D/A
• Accession: 0001578563-17-000005
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $6.0M
• Amount sold: $550K
• Remaining: $5.5M
• Minimum investment: $50K
• Investors: 9
• Date of first sale: 2016-11-23
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-275902

Issuer

• Name: Citius Pharmaceuticals, Inc.
• CIK: 0001506251
• Entity type: Corporation
• Jurisdiction: NEVADA
• Incorporated: 2010
• Address: 11 COMMERCE DRIVE 1ST FLOOR, CRANFORD, NJ, 07016
• Phone: (908) 967-6676

Officers, directors & promoters (20)

Other filings by this issuer (7)

More

• CIK 1506251 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search